Addex Therapeutics (SIX: ADXN and Nasdaq: ADXN), a clinical-stage biopharmaceutical company focused on developing a portfolio ...
Relay Therapeutics (Nasdaq: RLAY) is a clinical-stage, small molecule precision medicine company developing potentially ...
A new study finds miR-3663-3p is upregulated in chronic kidney disease patients with vascular calcification and promotes ...
- ASC30 reduced HbA1c by a placebo-adjusted 1.7%, 1.6% and 1.7% from baseline for 40 mg, 60 mg and 80 mg, respectively, at 12 ...
An international study investigating why wild tomatoes are more resistant to the tomato leafminer (Phthorimaea absoluta) than ...
Dr. Doom's MCU debut could lead to bigger events in the coming years, so it's a good time to get caught up on one of the ...
FDA grants orphan drug designation to oral OCT-980 for RHO-adRP, now in phase 1b/2 testing at US sites. The FDA granted ...
The Lynn Vance Show featured Magic Molecule, a hypochlorous acid spray designed to address various skin issues, which is ...
Cambridge Monte Carlo simulations published October 28, 2026 in Scientific Reports find comets struck early Earth too fast ...
Biotech Ukko launches trial for novel mRNA therapy for peanut allergy. It aims to retrain immune system by altering the ...
The Huntington's Disease Foundation (HDF) has awarded $2 million for its 2026 Transformative Research Awards (TRAs) to support two exceptional research collaborations with the potential to advance ...
The finding comes from researchers at Huntsman Cancer Institute at the University of Utah (the U), who identified a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results